About Trastuzumab (TRAZIMERA)
            
            Class: | Monoclonal antibody (HER2/neu receptor antagonist)  
Use: | Treatment of HER2-positive breast cancer, including metastatic breast cancer and adjuvant treatment of early-stage breast cancer  
Adult dose: | 8 mg/kg loading dose, followed by 6 mg/kg every 3 weeks or 2 mg/kg weekly, depending on the treatment regimen  
Pediatric dose: | Safety and efficacy not established in pediatric patients; use is not recommended  
Side effects: | Common side effects include fever, chills, nausea, vomit
         
        
            
                
                
                    
                        Drug Class
                    
                    Monoclonal antibody (HER2/neu receptor antagonist)
                 
                
                
                    
                        Uses & Indications
                    
                    Treatment of HER2-positive breast cancer, including metastatic breast cancer and adjuvant treatment of early-stage breast cancer
                 
                
                
                    
                        Storage Requirements
                    
                    Store at 2°C to 8°C (36°F to 46°F); do not freeze; protect from light; once reconstituted, use within 24 hours if stored at room temperature or within 48 hours if refrigerated
                 
                
                
                    
                        Manufacturer & Packaging
                    
                    
                        Manufacturer: Pfizer Canada ULC, Canada
                    
                    
                    Package Size
                    1 Glass Vial (15 ml)
                    
                    
                    Price & Supplier
                    
                        Price in UAE: AED 2534.50
                    
                    
                 
             
            
                
                
                    
                        Dosage Information
                    
                    
                        Adult Dose
                    
                    
                        8 mg/kg loading dose, followed by 6 mg/kg every 3 weeks or 2 mg/kg weekly, depending on the treatment regimen
                    
                    
                        Pediatric Dose
                    
                    
                        Safety and efficacy not established in pediatric patients; use is not recommended
                    
                 
                
                
                    
                        Side Effects
                    
                    Common side effects include fever, chills, nausea, vomiting, diarrhea, fatigue, headache, rash, and infusion-related reactions
                 
             
         
        
        
            
                Contraindications & Precautions
            
            Known hypersensitivity to trastuzumab or any component of the formulation; caution in patients with a history of cardiac disease
         
        
        
            
                Important Warnings
            
            Risk of cardiotoxicity, especially in patients receiving anthracycline-containing regimens; monitor cardiac function; potential for infusion-related reactions; pregnancy category D (risk to fetus)
         
        
        
        
        
        
        
        
        
        
        
            
                Medical Disclaimer
            
            
                This information is for educational purposes only and should not replace professional medical advice. 
                Always consult with a licensed healthcare provider or pharmacist in the UAE before taking any medication. 
                The information presented here is specific to medicines available in UAE pharmacies and is regularly updated 
                to ensure accuracy for patients and healthcare professionals in the United Arab Emirates.